Secondly, altered hematopoiesis is evident in the peripheral circulation with megakaryocyte-primed gene expression in the earliest CD34+CD38+ HSPCs, and expanded megakaryocyte progenitors in the response to COVID-19. The gene discussed is CD38; the disease is COVID-19.